Shares of Mankind Pharma surged nearly 6%, reaching an all-time high, after the pharmaceutical company secured a spot in the prestigious FTSE All-World, Large-Cap, Total-Cap,...
Mankind Pharma reported a stellar performance in its quarterly report for the April-June quarter of the current fiscal year. The drugmaker reported a 66.4% increase...
Private equity firm ChrysCapital-backed Mankind Pharma, the manufacturer of chart-topping condom brand Manforce Condoms, had decided the price band for its latest initial public offering...
Drugmaker Mankind Pharma’s initial public offering will open for subscription on April 25, according to Red Herring. The three-day initial public offering (IPO) will end...
According to Moneycontrol, private equity firm ChrysCapital-backed Mankind Pharma, maker of best-selling condom brand Manforce Condoms, has filed its DRHP with market regulator SEBI with...